Adjuvant Therapy for Esophageal Squamous Cell Carcinoma

by Jong-Mu Sun
Published 2020-08-01

PD-1/PD-L1 inhibitor therapy: transitioning from a second-line to a first-line therapy for non-small cell lung cancer

by Jong-Mu Sun
Published 2017-03-01

The Effectiveness of Maintenance Pharmacotherapies for Non-Small Cell Lung Cancer

by Myung-Ju Ahn, Jong-Mu Sun, Jin Sock Ahn, Keunchil Park
Published 2012-01-01

The Effectiveness of Maintenance Pharmacotherapies for Non-Small Cell Lung Cancer

by Myung-Ju Ahn, Jong-Mu Sun, Jin Sock Ahn, Keunchil Park
Published 2012-06-01

Prognostic and predictive value of KRAS mutations in advanced non-small cell lung cancer.

by Jong-Mu Sun, Deok Won Hwang, Jin Seok Ahn, Myung-Ju Ahn, Keunchil Park
Published 2013-01-01

Second primary pleomorphic carcinoma arising from the pneumonectomy cavity of non-small cell lung cancer: A case report

by Chaiyoung Lee, Byeong-Ho Jeong, Kyungjong Lee, Jae Il Zo, Jong-Mu Sun, Yoon-La Choi, Hojoong Kim
Published 2021-01-01

Treatment and Outcomes of Metastatic Non-Small-Cell Lung Cancer Harboring Uncommon <i>EGFR</i> Mutations: Are They Different from Those with Common <i>EGFR</i> Mutations?

by Hyun Ae Jung, Sehhoon Park, Jong-Mu Sun, Se-Hoon Lee, Jin Seok Ahn, Myung-Ju Ahn, Keunchil Park
Published 2020-10-01

Clinical outcomes of immune checkpoint inhibitors for patients with recurrent or metastatic head and neck cancer: real-world data in Korea

by Hyera Kim, Minsuk Kwon, Binnari Kim, Hyun Ae Jung, Jong-Mu Sun, Se-Hoon Lee, Keunchil Park, Myung-Ju Ahn
Published 2020-08-01

Acquired resistance to AZD9291 as an upfront treatment is dependent on ERK signaling in a preclinical model.

by Bo Mi Ku, Moon Ki Choi, Jong-Mu Sun, Se-Hoon Lee, Jin Seok Ahn, Keunchil Park, Myung-Ju Ahn
Published 2018-01-01

Role of 18F-FDG PET/CT in patients without known primary malignancy with skeletal lesions suspicious for cancer metastasis.

by Soo Bin Park, Jung Mi Park, Seung Hwan Moon, Young Seok Cho, Jong-Mu Sun, Byung-Tae Kim, Kyung-Han Lee
Published 2018-01-01

PD‐1 inhibitors for non‐small cell lung cancer patients with special issues: Real‐world evidence

by Seonggyu Byeon, Jang Ho Cho, Hyun Ae Jung, Jong‐Mu Sun, Se‐Hoon Lee, Jin Seok Ahn, Keunchil Park, Myung‐Ju Ahn
Published 2020-04-01

EGFR mutation testing in patients with advanced non-small cell lung cancer: a comprehensive evaluation of real-world practice in an East Asian tertiary hospital.

by Yoon-La Choi, Jong-Mu Sun, Juhee Cho, Sanjay Rampal, Joungho Han, Bhash Parasuraman, Eliseo Guallar, Genehee Lee, Jeeyun Lee, Young Mog Shim
Published 2013-01-01

DNA methylation loss promotes immune evasion of tumours with high mutation and copy number load

by Hyunchul Jung, Hong Sook Kim, Jeong Yeon Kim, Jong-Mu Sun, Jin Seok Ahn, Myung-Ju Ahn, Keunchil Park, Manel Esteller, Se-Hoon Lee, Jung Kyoon Choi
Published 2019-09-01

Predicting clinical benefit of immunotherapy by antigenic or functional mutations affecting tumour immunogenicity

by Kwoneel Kim, Hong Sook Kim, Jeong Yeon Kim, Hyunchul Jung, Jong-Mu Sun, Jin Seok Ahn, Myung-Ju Ahn, Keunchil Park, Se-Hoon Lee, Jung Kyoon Choi
Published 2020-02-01

Efficacy and safety of cisplatin and weekly docetaxel in patients with recurrent or metastatic squamous cell carcinoma of the head and neck

by Moon Jin Kim, Sung Min Kim, Hyun Ae Jung, Jung Yong Hong, Won Jin Chang, Moon Ki Choi, Hye Sook Kim, Jong-Mu Sun, Keunchil Park, Myung-Ju Ahn
Published 2019-09-01

Induction chemotherapy followed by concurrent chemoradiotherapy versus CCRT for locally advanced hypopharynx and base of tongue cancer

by Sung Hee Lim, Jong-Mu Sun, Joohyun Hong, Dongryul Oh, Yong Chan Ahn, Man Ki Chung, Han-Sin Jeong, Young-Ik Son, Myung-Ju Ahn, Chung-Hwan Baek, Keunchil Park
Published 2021-03-01

Clinical outcomes of radiation therapy for clinical T4b oesophageal cancer with airway invasion

by Hakyoung Kim, Dongryul Oh, Yong Chan Ahn, Keunchil Park, Myung-Ju Ahn, Se-Hoon Lee, Jong-Mu Sun, Young Mog Shim, Jae Ill Zo, Yong Soo Choi, Hong Kwan Kim, Jong Ho Cho
Published 2018-12-01

Immune-related adverse events are clustered into distinct subtypes by T-cell profiling before and early after anti-PD-1 treatment

by Kyung Hwan Kim, Joon Young Hur, Jinhyun Cho, Bo Mi Ku, Jiae Koh, June Young Koh, Jong-Mu Sun, Se-Hoon Lee, Jin Seok Ahn, Keunchil Park, Myung-Ju Ahn, Eui-Cheol Shin
Published 2020-01-01

Markedly increased ocular side effect causing severe vision deterioration after chemotherapy using new or investigational epidermal or fibroblast growth factor receptor inhibitors

by Eunhae Shin, Dong Hui Lim, Jisang Han, Do-Hyun Nam, Keunchil Park, Myung-Ju Ahn, Won Ki Kang, Jeeyun Lee, Jin Seok Ahn, Se-Hoon Lee, Jong-Mu Sun, Hyun Ae Jung, Tae-Young Chung
Published 2020-01-01

Paired whole exome and transcriptome analyses for the Immunogenomic changes during concurrent chemoradiotherapy in esophageal squamous cell carcinoma

by Sehhoon Park, Je-Gun Joung, Yang Won Min, Jae-Yong Nam, Daeun Ryu, Dongryul Oh, Woong-Yang Park, Se-Hoon Lee, Yoon La Choi, Jin Seok Ahn, Myung-Ju Ahn, Keunchil Park, Jong-Mu Sun
Published 2019-05-01